Patent · US Active

Method for glucose monitoring using fluorescence quenching

US8088595B2 · kind B2 · utility

14Cited by
10References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 2010
Grant dateJan 3, 2012
Priority date
Expiry dateApr 29, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/54366
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

This disclosure relates to a method of measuring a glucose concentration metric or a glucose metric in a patient by contacting an implantable glucose-sensing device with a test sample, which may be in the patient, under conditions that permit a sugar-binding molecule and a functionalized polymer or nano-particle ligand present throughout the matrix of a hydrogel to interact in a glucose-dependent manner to produce an optical signal resulting from quenching of a first fluorophore linked to the ligand or sugar-binding molecule and having a fluorescent emission spectrum quenched upon binding or release of glucose. Next the first fluorophore may be excited with light of a certain wavelength. Then at least one wavelength of light in the glucose-dependent optical signal from the fluorophore may be detected with a detector to produce a detected light signal, which may be processed to produce a glucose metric, such as a glucose concentration metric.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.